Moreover, activation of the AMPK/mTOR signaling pathway with rapamycin inhibited EMT and proliferation by increasing epithelial marker expression (e.g., E-cadherin) and reducing mesenchymal marker expression in prostate cancer cells. The gene discussed is CDH1; the disease is prostate cancer.